| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2500248 | 注射用人白介素-2（高亲和型复合物） | Recombinant Human Interleukin-2 | Lyophilized | Biological Products(1) | New Drug Application | 2025-03-27 | Beijing Liangyuan Biomedical Research Co Ltd | view |